This study is in progress, not accepting new patients
PALbociclib CoLlaborative Adjuvant Study
a study on Breast Cancer
Breast Cancer, HR+/HER2- breast cancer, Palbociclib, Breast Neoplasms
Lead Scientist at UCSF
- Hope Rugo
Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. A Clinical Professor of Medicine, Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at UCSF in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Alliance Foundation Trials, LLC.
- Phase 3 Breast Cancer Research Study
- Study Type
- About 5796 people participating
- Last Updated